Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On August 3, 2023, ResMed reported results for the fourth quarter of fiscal 2023. Analysts lowered their ratings in response to ResMed’s report, citing concerns over market share and gross margins. Following ResMed’s announcements, on August 4, 2023, ResMed’s stock price fell from $219.95 per share to $179.25 per share, a decline of more than $40 per share.